Amphastar Seeks Court Order Requiring FDA To Approve Its Enoxaparin ANDA

Amphastar’s initial lawsuit against FDA achieved its stated goal: the agency released two shipments of raw heparin material the company is to use in producing generic Lovenox (enoxaparin).